BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36555229)

  • 1. Hydroxychloroquine Mitigates Dilated Cardiomyopathy Phenotype in Transgenic D94A Mice.
    Kanashiro-Takeuchi RM; Kazmierczak K; Liang J; Takeuchi LM; Sitbon YH; Szczesna-Cordary D
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified
    Yuan CC; Kazmierczak K; Liang J; Zhou Z; Yadav S; Gomes AV; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2338-E2347. PubMed ID: 29463717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of force-pCa relation in
    Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation Mimetic of Myosin Regulatory Light Chain Mitigates Cardiomyopathy-Induced Myofilament Impairment in Mouse Models of RCM and DCM.
    Kazmierczak K; Liang J; Maura LG; Scott NK; Szczesna-Cordary D
    Life (Basel); 2023 Jun; 13(7):. PubMed ID: 37511838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain.
    Huang W; Liang J; Yuan CC; Kazmierczak K; Zhou Z; Morales A; McBride KL; Fitzgerald-Butt SM; Hershberger RE; Szczesna-Cordary D
    FEBS J; 2015 Jun; 282(12):2379-93. PubMed ID: 25825243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
    Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
    FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
    Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin.
    Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D
    J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.
    Huang W; Szczesna-Cordary D
    J Muscle Res Cell Motil; 2015 Dec; 36(6):433-45. PubMed ID: 26385864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.
    Yadav S; Sitbon YH; Kazmierczak K; Szczesna-Cordary D
    Pflugers Arch; 2019 May; 471(5):683-699. PubMed ID: 30706179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tail length and E525K dilated cardiomyopathy mutant alter human β-cardiac myosin super-relaxed state.
    Duno-Miranda S; Nelson SR; Rasicci DV; Bodt SML; Cirilo JA; Vang D; Sivaramakrishnan S; Yengo CM; Warshaw DM
    J Gen Physiol; 2024 Jun; 156(6):. PubMed ID: 38709176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional comparison of phosphomimetic S15D and T160D mutants of myosin regulatory light chain exchanged in cardiac muscle preparations of HCM and WT mice.
    Kazmierczak K; Liang J; Gomez-Guevara M; Szczesna-Cordary D
    Front Cardiovasc Med; 2022; 9():988066. PubMed ID: 36204565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
    Kerrick WG; Kazmierczak K; Xu Y; Wang Y; Szczesna-Cordary D
    FASEB J; 2009 Mar; 23(3):855-65. PubMed ID: 18987303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
    Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
    Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilated cardiomyopathy mutation E525K in human beta-cardiac myosin stabilizes the interacting-heads motif and super-relaxed state of myosin.
    Rasicci DV; Tiwari P; Bodt SML; Desetty R; Sadler FR; Sivaramakrishnan S; Craig R; Yengo CM
    Elife; 2022 Nov; 11():. PubMed ID: 36422472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of AAV9-S15D-RLC gene delivery in humanized MYL2 mouse model of HCM.
    Yadav S; Yuan CC; Kazmierczak K; Liang J; Huang W; Takeuchi LM; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    J Mol Med (Berl); 2019 Jul; 97(7):1033-1047. PubMed ID: 31101927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.
    Muthu P; Liang J; Schmidt W; Moore JR; Szczesna-Cordary D
    Arch Biochem Biophys; 2014 Jun; 552-553():29-39. PubMed ID: 24374283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model.
    Tarigopula M; Davis RT; Mungai PT; Ryba DM; Wieczorek DF; Cowan CL; Violin JD; Wolska BM; Solaro RJ
    Cardiovasc Res; 2015 Jul; 107(2):226-34. PubMed ID: 26045475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.